Ligand validation:3SZD

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 3SZD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3SZD_C8E_B_407	33%	90%	0.121	0.912	0.44	0.19	-	-	0	0	38%	0.381
3SZD_C8E_A_408	29%	85%	0.174	0.874	0.47	0.28	-	-	0	0	76%	0.7619
3SZD_C8E_B_408	26%	78%	0.2	0.861	0.4	0.49	-	-	7	0	90%	0.9048
3SZD_C8E_A_407	25%	82%	0.164	0.857	0.46	0.35	-	-	0	0	67%	0.6667
3SZD_C8E_B_406	24%	86%	0.194	0.941	0.31	0.4	-	-	2	0	33%	0.3333
4FMS_C8E_B_404	40%	78%	0.179	0.888	0.39	0.5	-	-	2	0	100%	1
2VQI_C8E_B_1638	100%	84%	0.037	0.989	0.38	0.39	-	-	0	0	100%	1
2GR7_C8E_D_1342	83%	75%	0.098	0.955	0.42	0.56	-	-	2	0	100%	1
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	0	100%	1
3QRC_C8E_B_1	76%	86%	0.113	0.95	0.37	0.36	-	-	0	0	100%	1
3RGN_C8E_A_800	76%	74%	0.112	0.947	0.34	0.66	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.